Large-scale testing (Phase 3)Ended earlyNCT03409679What this trial is testingPivotal Study in VAP Suspected or Confirmed to be Due to Pseudomonas AeruginosaWho this might be right forPneumonia Polyphor Ltd. 41
Not applicableUnknownNCT05880069What this trial is testingClinical Outcomes in Patients With Infection by Resistant MicroorganismWho this might be right forPneumoniaBloodstream InfectionUrinary Tract Infections+8 more Hospital Universitario Virgen Macarena 5,000
Testing effectiveness (Phase 2)Study completedNCT00633191What this trial is testingAnti-pseudomonas IgY to Prevent Infections in Cystic FibrosisWho this might be right forCystic FibrosisInfectionPseudomonas Aeruginosa Immunsystem AB 14
Early research (Phase 1)Study completedNCT00778388What this trial is testingStudy Assessing Safety and Immunogenicity of IC43 Vaccination Against Pseudomonas Aeruginosa in Healthy VolunteersWho this might be right forHealthy Valneva Austria GmbH 157
Large-scale testing (Phase 3)Study completedNCT01577368What this trial is testingPiperacillin-Tazobactam Continuous Versus Intermittent Infusion for Pseudomonas AeruginosaWho this might be right forPseudomonas Aeruginosa Infection Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 76
Post-approval studies (Phase 4)Active Not RecruitingNCT05210439What this trial is testingEfficacy and Safety of 7 Versus 14 Days of Antibiotic Treatment for Pseudomonas Aeruginosa BacteraemiaWho this might be right forBloodstream Infection Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 306
Not applicableNot Yet RecruitingNCT07703644What this trial is testingCeftazidime-Avibactam PK/PD and Resistance in Hematology PatientsWho this might be right forHematologic NeoplasmsGram-Negative Bacterial InfectionsPseudomonas Aeruginosa Infection+2 more Sizhou Feng 60
Not applicableStudy completedNCT02449031What this trial is testingObservational Study in Cystic Fibrosis Patients Using TOBI® PODHALER® or Other FDA Approved Inhaled Antipseudomonal Antibacterial DrugsWho this might be right forPseudomonas Aeruginosa in Cystic Fibrosis Mylan Inc. 409
Large-scale testing (Phase 3)Study completedNCT01069705What this trial is testingSecond Open Label Extension to Bridging Study CTBM100C2303Who this might be right forPulmonary InfectionsPseudomonas Aeruginosa Novartis Pharmaceuticals 49
Large-scale testing (Phase 3)Study completedNCT00104520What this trial is testingSafety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Cystic Fibrosis Patients With P. AeruginosaWho this might be right forCystic Fibrosis Gilead Sciences 211
Large-scale testing (Phase 3)Study completedNCT00712166What this trial is testingSafety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Patients With Cystic Fibrosis, Mild Lung Disease, and P. AeruginosaWho this might be right forCystic FibrosisLung InfectionPseudomonas Aeruginosa Gilead Sciences 160
Testing effectiveness (Phase 2)UnknownNCT03669614What this trial is testingSAD and MAD of Inhaled AR-501 in Health Adults and P. Aeruginosa Infected Cystic Fibrosis SubjectsWho this might be right forCystic Fibrosis Aridis Pharmaceuticals, Inc. 102
Testing effectiveness (Phase 2)Study completedNCT05616221What this trial is testingStudy to Evaluate the Safety, Phage Kinetics, and Efficacy of Inhaled AP-PA02 in Subjects With Non-Cystic Fibrosis Bronchiectasis and Chronic Pulmonary Pseudomonas Aeruginosa InfectionWho this might be right forNon-cystic Fibrosis BronchiectasisPseudomonas AeruginosaLung Infection Armata Pharmaceuticals, Inc. 48
Large-scale testing (Phase 3)Not Yet RecruitingNCT07804082What this trial is testingA Double-Blind, Placebo-Controlled Study of Nebulized Bacteriophages in Patients With Ventilator-Associated Pneumonia Due to Pseudomonas AeruginosaWho this might be right forVentilator Associated Bacterial PneumoniaPseudomonas Aeruginosa Infection Assistance Publique - Hôpitaux de Paris 184
Testing effectiveness (Phase 2)Study completedNCT02354859What this trial is testingIV Gallium Study for Patients With Cystic Fibrosis (IGNITE Study)Who this might be right forCystic Fibrosis University of Washington 119
Testing effectiveness (Phase 2)Ended earlyNCT01570192What this trial is testingClinical Trials to Reduce the Risk of Antimicrobial ResistanceWho this might be right forBacterial Pneumonia University of Florida 43
Not applicableStudy completedNCT00531531What this trial is testingEvaluation of the Emission Distance of P. Aeruginosa From the Respiratory Tract of People With Cystic FibrosisWho this might be right forCystic Fibrosis University of Florence 42
Testing effectiveness (Phase 2)UnknownNCT06319235What this trial is testingClinical Trial to Demonstrate the Safety and Efficacy of DUOFAG®Who this might be right forSurgical Site InfectionStaphylococcus Aureus InfectionPseudomonas Aeruginosa Infection+2 more MB PHARMA s.r.o. 52
Not applicableUnknownNCT05285046What this trial is testingPhenotypic Profile and Molecular Mechanism of Resistance in Carbapenemase-producing Enterobacterales and Pseudomonas Aeruginosa Isolates From Brazilian Hospitals: Implications for the Introduction of IMIPENEM-RELEBACTAMWho this might be right forBacterial InfectionsAntibiotic Resistant Infection D'Or Institute for Research and Education 250
Not applicableNo Longer AvailableNCT03395743What this trial is testingIndividual Patient Expanded Access for AB-PA01, an Investigational Anti-Pseudomonas Aeruginosa Bacteriophage Therapeutic Armata Pharmaceuticals, Inc.